These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 22543447)

  • 21. Nanogated vessel based on polypseudorotaxane-capped mesoporous silica via a highly acid-labile benzoic-imine linker.
    Gao Y; Ma R; An Y; Shi L
    J Control Release; 2011 Nov; 152 Suppl 1():e81-2. PubMed ID: 22195943
    [No Abstract]   [Full Text] [Related]  

  • 22. Controlled drug delivery system based on ordered mesoporous silica matrices of captopril as angiotensin-converting enzyme inhibitor drug.
    Popovici RF; Seftel EM; Mihai GD; Popovici E; Voicu VA
    J Pharm Sci; 2011 Feb; 100(2):704-14. PubMed ID: 20740675
    [TBL] [Abstract][Full Text] [Related]  

  • 23. pH-Triggered controlled drug release from mesoporous silica nanoparticles via intracelluar dissolution of ZnO nanolids.
    Muhammad F; Guo M; Qi W; Sun F; Wang A; Guo Y; Zhu G
    J Am Chem Soc; 2011 Jun; 133(23):8778-81. PubMed ID: 21574653
    [TBL] [Abstract][Full Text] [Related]  

  • 24. NIR-enhanced drug release from porous Au/SiO2 nanoparticles.
    Yagüe C; Arruebo M; Santamaria J
    Chem Commun (Camb); 2010 Oct; 46(40):7513-5. PubMed ID: 20830418
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pore spanning lipid bilayers on mesoporous silica having varying pore size.
    Claesson M; Frost R; Svedhem S; Andersson M
    Langmuir; 2011 Jul; 27(14):8974-82. PubMed ID: 21650458
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lipid coated mesoporous silica nanoparticles as photosensitive drug carriers.
    Yang Y; Song W; Wang A; Zhu P; Fei J; Li J
    Phys Chem Chem Phys; 2010 May; 12(17):4418-22. PubMed ID: 20407714
    [TBL] [Abstract][Full Text] [Related]  

  • 27. All-Silica Submicrometer Colloidosomes for Cargo Protection and Tunable Release.
    Jiang H; Hong L; Li Y; Ngai T
    Angew Chem Int Ed Engl; 2018 Sep; 57(36):11662-11666. PubMed ID: 30030905
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Smart drug delivery through DNA/magnetic nanoparticle gates.
    Ruiz-Hernández E; Baeza A; Vallet-Regí M
    ACS Nano; 2011 Feb; 5(2):1259-66. PubMed ID: 21250653
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Size effect on cell uptake in well-suspended, uniform mesoporous silica nanoparticles.
    Lu F; Wu SH; Hung Y; Mou CY
    Small; 2009 Jun; 5(12):1408-13. PubMed ID: 19296554
    [No Abstract]   [Full Text] [Related]  

  • 30. A facile route for rapid synthesis of hollow mesoporous silica nanoparticles as pH-responsive delivery carrier.
    Xu H; Zhang H; Wang D; Wu L; Liu X; Jiao Z
    J Colloid Interface Sci; 2015 Aug; 451():101-7. PubMed ID: 25890118
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cathepsin-B induced controlled release from peptide-capped mesoporous silica nanoparticles.
    de la Torre C; Mondragón L; Coll C; Sancenón F; Marcos MD; Martínez-Máñez R; Amorós P; Pérez-Payá E; Orzáez M
    Chemistry; 2014 Nov; 20(47):15309-14. PubMed ID: 25303093
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Drug encapsulation and release by mesoporous silica nanoparticles: the effect of surface functional groups.
    Tan SY; Ang CY; Li P; Yap QM; Zhao Y
    Chemistry; 2014 Sep; 20(36):11276-82. PubMed ID: 25044108
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Study of mesoporous silica/magnetite systems in drug controlled release.
    Souza KC; Ardisson JD; Sousa EM
    J Mater Sci Mater Med; 2009 Feb; 20(2):507-12. PubMed ID: 18839283
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Controlled delivery using oligonucleotide-capped mesoporous silica nanoparticles.
    Climent E; Martínez-Máñez R; Sancenón F; Marcos MD; Soto J; Maquieira A; Amorós P
    Angew Chem Int Ed Engl; 2010 Sep; 49(40):7281-3. PubMed ID: 20737526
    [No Abstract]   [Full Text] [Related]  

  • 35. Magnetic mesoporous silica spheres for hyperthermia therapy.
    Martín-Saavedra FM; Ruíz-Hernández E; Boré A; Arcos D; Vallet-Regí M; Vilaboa N
    Acta Biomater; 2010 Dec; 6(12):4522-31. PubMed ID: 20601238
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vesicle adsorption on mesoporous silica and titania.
    Claesson M; Cho NJ; Frank CW; Andersson M
    Langmuir; 2010 Nov; 26(22):16630-3. PubMed ID: 20932045
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preparation and characterization of iron oxide-silica composite particles using mesoporous SBA-15 silica as template and their internalization into mesenchymal stem cell and human bone cell lines.
    Yiu HH; Maple MJ; Lees MR; Palona I; El Haj AJ; Dobson J
    IEEE Trans Nanobioscience; 2010 Sep; 9(3):165-70. PubMed ID: 20615817
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mesoporous silica nanoparticles for intracellular controlled drug delivery.
    Vivero-Escoto JL; Slowing II; Trewyn BG; Lin VS
    Small; 2010 Sep; 6(18):1952-67. PubMed ID: 20690133
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Macrophage entrapped silica coated superparamagnetic iron oxide particles for controlled drug release in a 3D cancer model.
    Ullah S; Seidel K; Türkkan S; Warwas DP; Dubich T; Rohde M; Hauser H; Behrens P; Kirschning A; Köster M; Wirth D
    J Control Release; 2019 Jan; 294():327-336. PubMed ID: 30586597
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Control-release microcapsule of famotidine loaded biomimetic synthesized mesoporous silica nanoparticles: Controlled release effect and enhanced stomach adhesion in vitro.
    Li J; Wang H; Yang B; Xu L; Zheng N; Chen H; Li S
    Mater Sci Eng C Mater Biol Appl; 2016 Jan; 58():273-7. PubMed ID: 26478311
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.